1. Home
  2. LTRN vs COCH Comparison

LTRN vs COCH Comparison

Compare LTRN & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$0.40

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

N/A

Current Price

$6.90

Market Cap

51.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LTRN
COCH
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
51.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
LTRN
COCH
Price
$0.40
$6.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$17.50
★ $19.67
AVG Volume (30 Days)
★ 217.0K
31.8K
Earning Date
12-01-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 18.65
17.45
EPS
★ N/A
N/A
Revenue
N/A
★ $241,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.33
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.11
52 Week Low
$0.38
$4.72
52 Week High
$4.34
$47.70

Technical Indicators

Market Signals
Indicator
LTRN
COCH
Relative Strength Index (RSI) 25.77 19.48
Support Level N/A $4.72
Resistance Level $0.84 $7.46
Average True Range (ATR) 0.09 0.47
MACD 0.01 1.04
Stochastic Oscillator 3.10 58.20

Price Performance

Historical Comparison
LTRN
COCH

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: